
Cape Biologix Technologies develops and manufactures plant-made, recombinant monoclonal proteins. We use our plants as single-use, biodegradable bioreactors to produce pharmaceutically relevant proteins for multiple uses across diagnostics, vaccines, or therapeutic applications. As you might have noticed, we LOVE plants. We love them so much in fact that we're on a mission to use plant biotechnology to improve the well-being of people, animals, and plants Feel free to reach out to us if you're like to connect.
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.